loading
Schlusskurs vom Vortag:
$1.39
Offen:
$1.39
24-Stunden-Volumen:
134.90K
Relative Volume:
0.90
Marktkapitalisierung:
$181.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.84M
KGV:
-12.51
EPS:
-0.1143
Netto-Cashflow:
$-8.76M
1W Leistung:
+14.40%
1M Leistung:
+14.40%
6M Leistung:
-22.28%
1J Leistung:
+17.21%
1-Tages-Spanne:
Value
$1.355
$1.46
1-Wochen-Bereich:
Value
$1.23
$1.46
52-Wochen-Spanne:
Value
$1.14
$2.60

Tiziana Life Sciences Ltd Stock (TLSA) Company Profile

Name
Firmenname
Tiziana Life Sciences Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
9
Name
Twitter
@tizianals
Name
Nächster Verdiensttermin
2026-05-05
Name
Neueste SEC-Einreichungen
Name
TLSA's Discussions on Twitter

Compare TLSA vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
TLSA icon
TLSA
Tiziana Life Sciences Ltd
1.43 181.96M 0 -12.84M -8.76M -0.1143
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 107.87B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 73.63B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 49.42B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 40.20B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.06B 5.36B 287.73M 924.18M 2.5229

Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-12-22 Eingeleitet B. Riley Securities Buy
2018-12-17 Eingeleitet Laidlaw Buy

Tiziana Life Sciences Ltd Aktie (TLSA) Neueste Nachrichten

pulisher
12:22 PM

TLSA SEC FilingsTiziana Life Sciences Ltd Com 10-K, 10-Q, 8-K Forms - Stock Titan

12:22 PM
pulisher
May 02, 2026

Tiziana Life Sciences | 20-F: Registration statement / Annual report / Transition report - Moomoo

May 02, 2026
pulisher
May 01, 2026

Tiziana Life Sciences (TLSA) posts 2025 loss and faces going concern risk - Stock Titan

May 01, 2026
pulisher
Apr 30, 2026

Tiziana Life Sciences Delays Annual 20-F Filing - TipRanks

Apr 30, 2026
pulisher
Apr 23, 2026

Tiziana (TLSA) Stock: In-Depth Look (Mini Selloff) 2026-04-23Growth Investing - Newser

Apr 23, 2026
pulisher
Apr 18, 2026

Wall Street Zen Downgrades Tiziana Life Sciences (NASDAQ:TLSA) to Sell - MarketBeat

Apr 18, 2026
pulisher
Apr 16, 2026

Tiziana (TLSA) Stock Large Cap Focus (Hovering) 2026-04-16Most Discussed Stocks - Cổng thông tin điện tử Tỉnh Sơn La

Apr 16, 2026
pulisher
Apr 16, 2026

Small cap wrap: 1911 Gold, Sona Nanotech, Tiziana Life Sciences, Gunnison Copper… - Proactive financial news

Apr 16, 2026
pulisher
Apr 16, 2026

Tiziana Life Sciences (TLSA) Unveils Promising Preclinical Findi - GuruFocus

Apr 16, 2026
pulisher
Apr 16, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 16, 2026
pulisher
Apr 16, 2026

Tiziana says intranasal drug shows potential to ease Long COVID “brain fog” - Yahoo! Finance Canada

Apr 16, 2026
pulisher
Apr 16, 2026

Tiziana reports preclinical data on intranasal foralumab for Long COVID - Investing.com

Apr 16, 2026
pulisher
Apr 16, 2026

Tiziana reports preclinical data on intranasal foralumab for Long COVID By Investing.com - Investing.com UK

Apr 16, 2026
pulisher
Apr 16, 2026

Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function - The Manila Times

Apr 16, 2026
pulisher
Apr 16, 2026

A nasal antibody cut brain inflammation in a Long COVID mouse study - Stock Titan

Apr 16, 2026
pulisher
Apr 16, 2026

Tiziana Life Sciences (Nasdaq: TLSA) reports promising Long COVID preclinical results - Stock Titan

Apr 16, 2026
pulisher
Apr 14, 2026

Market movers: Tesla, Wells Fargo, Lucid Group, Tiziana Life Sciences, Trillion Energy… - Proactive financial news

Apr 14, 2026
pulisher
Apr 14, 2026

Tiziana Life Sciences’ Intranasal Foralumab MSA Trial Highlighted in Late-Breaking Poster at 7th World Parkinson Congress - TipRanks

Apr 14, 2026
pulisher
Apr 14, 2026

Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress - The Manila Times

Apr 14, 2026
pulisher
Apr 14, 2026

Tiziana Life Sciences (TLSA) highlights Phase 2a intranasal foralumab MSA trial at World Parkinson Congress - Stock Titan

Apr 14, 2026
pulisher
Apr 14, 2026

Tiziana Life Sciences to present Phase 2a MSA study at World Parkinson Congress - Proactive financial news

Apr 14, 2026
pulisher
Apr 14, 2026

Tiziana Life Sciences Ltd. - Via Ritzau

Apr 14, 2026
pulisher
Apr 10, 2026

Can Tiziana (TLSA) Stock Recover Now | Price at $1.24, Down 1.59%Fast Rising Picks - Newser

Apr 10, 2026
pulisher
Apr 07, 2026

Aug Setups: What is the Moat Score of BlackRock Virginia Municipal Bond Trust2026 Pullback Review & Stock Timing and Entry Methods - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 05, 2026

Swing Trade: Can Tiziana Life Sciences Ltd maintain its current growth ratePortfolio Gains Report & Consistent Return Investment Signals - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 04, 2026

Downgrade Watch: Is Tiziana Life Sciences Ltd a cyclical or defensive stockMarket Risk Analysis & Reliable Entry Point Alerts - baoquankhu1.vn

Apr 04, 2026
pulisher
Apr 04, 2026

TLSA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 04, 2026
pulisher
Apr 02, 2026

Tiziana Life Sciences (NASDAQ:TLSA) Trading 6.8% HigherHere's What Happened - MarketBeat

Apr 02, 2026
pulisher
Apr 01, 2026

Market movers: Nike, RH, Tiziana Life Sciences, Eli Lilly… - Proactive financial news

Apr 01, 2026
pulisher
Apr 01, 2026

Tiziana Life Sciences Stock Jumps As Positive Preclinical Fuels Momentum - Benzinga

Apr 01, 2026
pulisher
Apr 01, 2026

Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging - Bitget

Apr 01, 2026
pulisher
Apr 01, 2026

Tiziana Life Sciences reports positive preclinical findings for intranasal anti-CD3 therapy in brain aging - Proactive financial news

Apr 01, 2026
pulisher
Apr 01, 2026

Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline - TipRanks

Apr 01, 2026
pulisher
Apr 01, 2026

Tiziana Life Sciences (NASDAQ: TLSA) posts positive nasal anti-CD3 data in aging model - Stock Titan

Apr 01, 2026
pulisher
Apr 01, 2026

Tiziana Life Sciences Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging - marketscreener.com

Apr 01, 2026
pulisher
Mar 31, 2026

Volume Report: What are the future prospects of Tiziana Life Sciences LtdInflation Watch & Real-Time Market Sentiment Alerts - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 27, 2026

Update Report: Does Tiziana Life Sciences Ltd outperform in volatile marketsQuarterly Trade Report & Risk Managed Investment Signals - baoquankhu1.vn

Mar 27, 2026
pulisher
Mar 26, 2026

Aug Outlook: Does Tiziana Life Sciences Ltd offer margin of safety2026 Chart Watch & Safe Capital Allocation Plans - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 22, 2026

If You Invested $1,000 in Tiziana Life Sciences Ltd Com (TLSA) - Stock Titan

Mar 22, 2026
pulisher
Mar 20, 2026

Tiziana Life Sciences Ltd: Fundamental Analysis and Financial Ratings | 0RP | BMG889121031 - marketscreener.com

Mar 20, 2026
pulisher
Mar 19, 2026

Macro Review: Is Tiziana Life Sciences Ltd stock a good dividend stock2026 Retail Activity & Verified Swing Trading Watchlists - baoquankhu1.vn

Mar 19, 2026
pulisher
Mar 18, 2026

Large TLSA stake reported by director Gabriele M. Cerrone on Form 3 - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Macro Review: Is Tiziana Life Sciences Ltd subject to activist investor interest2026 Closing Moves & Weekly Sector Rotation Insights - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 17, 2026

Forecast Cut: Can Tiziana Life Sciences Ltd maintain its current growth rate2026 Big Picture & Fast Moving Stock Watchlists - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

Price Action: Can Tiziana Life Sciences Ltd be recession proofTrade Risk Report & High Accuracy Investment Signals - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 13, 2026

TLSA Earnings History & Surprises | EPS & Revenue Results | TIZIANA LIFE SCIENCES LTD (NASDAQ:TLSA) - ChartMill

Mar 13, 2026
pulisher
Mar 12, 2026

Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Down 4.4%Should You Sell? - MarketBeat

Mar 12, 2026
pulisher
Mar 11, 2026

Tiziana Life Sciences (TLSA) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 11, 2026
pulisher
Mar 11, 2026

Whats next for Tiziana Life Sciences Ltd stockAnalyst Upgrade & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Mar 11, 2026
pulisher
Mar 10, 2026

New Highs: Can Tiziana Life Sciences Ltd expand its profit margins2026 Sector Moves & Fast Gaining Stock Reports - baoquankhu1.vn

Mar 10, 2026
pulisher
Mar 08, 2026

Aug Macro: Is Tiziana Life Sciences Ltd a stock for growth or value investorsMarket Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Mar 08, 2026

Finanzdaten der Tiziana Life Sciences Ltd-Aktie (TLSA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
Kapitalisierung:     |  Volumen (24h):